117 related articles for article (PubMed ID: 2259224)
1. Control of actin conformation in AML myeloblasts: the effects of bryostatin and TPA.
Sham RL; Packman CH; Abboud CN; Lichtman MA
Leuk Res; 1990; 14(10):863-8. PubMed ID: 2259224
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction and the regulation of actin conformation during myeloid maturation: studies in HL60 cells.
Sham RL; Packman CH; Abboud CN; Lichtman MA
Blood; 1991 Jan; 77(2):363-70. PubMed ID: 1985701
[TBL] [Abstract][Full Text] [Related]
3. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL; Bradshaw TD; Gescher A; Pettit GR
Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
[TBL] [Abstract][Full Text] [Related]
5. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
6. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
Steube KG; Grunicke D; Quentmeier H; Drexler HG
Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
Boorne AJ; Donnelly N; Schrey MP
Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.
Jones RJ; Sharkis SJ; Miller CB; Rowinsky EK; Burke PJ; May WS
Blood; 1990 Mar; 75(6):1319-23. PubMed ID: 2310830
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells.
Jalava A; Lintunen M; Heikkilä J
Biochem Biophys Res Commun; 1993 Mar; 191(2):472-8. PubMed ID: 8461005
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin 1 antagonizes the terminal differentiating action of 12-O-tetradecanoylphorbol-13-acetate in a human colon cancer cell.
McBain JA; Pettit GR; Mueller GC
Carcinogenesis; 1988 Jan; 9(1):123-9. PubMed ID: 3335036
[TBL] [Abstract][Full Text] [Related]
13. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
Grant S; Pettit GR; Howe C; McCrady C
Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of polymyxin B, phorbol ester and bryostatin on protein phosphorylation, protein kinase C translocation, phospholipid metabolism and differentiation of HL60 cells.
Kiss Z; Deli E; Girard PR; Pettit GR; Kuo JF
Biochem Biophys Res Commun; 1987 Jul; 146(1):208-15. PubMed ID: 3038105
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
Nutt JE; Harris AL; Lunec J
Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.
Hennings H; Blumberg PM; Pettit GR; Herald CL; Shores R; Yuspa SH
Carcinogenesis; 1987 Sep; 8(9):1343-6. PubMed ID: 3621472
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a.
Kiss Z; Deli E; Shoji M; Koeffler HP; Pettit GR; Vogler WR; Kuo JF
Cancer Res; 1987 Mar; 47(5):1302-7. PubMed ID: 3469014
[TBL] [Abstract][Full Text] [Related]
18. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
[TBL] [Abstract][Full Text] [Related]
19. Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.
Smith JB; Smith L; Pettit GR
Biochem Biophys Res Commun; 1985 Nov; 132(3):939-45. PubMed ID: 3907633
[TBL] [Abstract][Full Text] [Related]
20. The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3.
van der Hem KG; Dräger AM; Huijgens PC; Tol C; Devillé W; Langenhuijsen MM
Leukemia; 1994 Feb; 8(2):266-73. PubMed ID: 7508534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]